Major Pharmaceuticals: Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, Rx only, Packaged and Distributed
Read the official notice at FDA (drug) →
Get alerts for Major Pharmaceuticals
The text below is copied from the official FDA (drug) record. If anything differs, the official notice is correct.
- Company / brand
- Major Pharmaceuticals
- Product
- Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. NDC: 0904-6951-61
- Reason / hazard
- Subpotent Drug
- Classification
- Class II
- Status
- Ongoing
- Distribution / sold at
- Nationwide in the USA.
- Recall initiated
- 2026-07-13
- Code info
- Lot# N02172, exp 07/2026; N02296, N02288, Exp. Date 12/2026
- Product quantity
- N/A
- Voluntary mandated
- Voluntary: Firm initiated
- City
- Dublin
- State
- OH
- Country
- United States
- Event id
- 99399
Free daily digest + "My products" watchlist